Javitt, Daniel C.
Sweet, Robert A.
Article History
First Online: 20 August 2015
Competing interests
: D.C. J. has acted as a consultant for Forum and Takeda, has received a grant from Roche and has been part of an advisory board for Promentis and NeuroRx. He also holds stock in Glytech and NeuroRx and has patents for <scp>D</scp>-serine in the treatment of schizophrenia and d-cycloserine in the treatment of depression. R.A.S. declares no competing interests.